loader
Page is loading...
Print Logo Logo
microscope


SPEAKERS

Deborah Pollack Milgate

Deborah Pollack-Milgate

Partner
Vice-Chair of the European Practice Group
Kristin Jones

Kristin Jones

President and CEO
Indiana Life Sciences Association
Oscar Moralez

Oscar Moralez

Founder and Managing Partner
Boomerang Ventures
Ken Schafer

Dr. Ken Schafer

Greenfield Pathology Services
Bob Seevers

Bob Seevers, Ph.D.

Senior Advisor
Pearl Pathway



SPEAKERS

Deborah Pollack Milgate

Deborah Pollack-Milgate

Partner
Vice-Chair of the European Practice Group
Kristin Jones

Kristin Jones

President and CEO
Indiana Life Sciences Association
Oscar Moralez

Oscar Moralez

Founder and Managing Partner
Boomerang Ventures
Ken Schafer

Dr. Ken Schafer

Greenfield Pathology Services
Bob Seevers

Bob Seevers, Ph.D.

Senior Advisor
Pearl Pathway

Even at the earliest stages, bioscience companies need to have a good plan and understanding of key milestones if they hope to grow. Starting off well can save both valuable time and resources.

Please join us as our panelists delve into the basics of pre-clinical business plans, determining the best regulatory pathway, performing toxicology studies and generating other key analytical data, and discussing how to best protect your intellectual property. The choices made at this stage can affect your business for years to come, so make sure you’re prepared!

Questions? Email Siara Reyes or call 317-231-7211.

Trending Connect
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to use cookies.